All results
2 results for randomized double blind multiple dose placebo controlled study evaluate safety
-
ATYR
This randomized, double-blind, placebo matched to efzofitimod-controlled, study will evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK),…
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
ALXN2050-NEPH-201
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…
- Ages
- 18 Years - 75 Years
- Sexes
- All